HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/4/R1754    most recent 00145.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Rigsby, C. S. Articles by Dorrance, A. M. Search for Related Content PubMed PubMed Citation Articles by Rigsby, C. S. Articles by Dorrance, A. M.

WATER AND ELECTROLYTE HOMEOSTASIS

Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists

¹Department of Physiology, and ²Vascular Biology Center, Medical College of Georgia, Augusta, Georgia

Submitted 28 February 2007 ; accepted in final form 25 July 2007

Data from the Framingham Heart Study suggest that women may be more sensitive to the deleterious cardiovascular remodeling effects of aldosterone. Previous studies from our laboratory have shown that chronic treatment with spironolactone, a mineralocorticoid receptor (MR) antagonist, decreases ischemic cerebral infarct size and prevents remodeling of the middle cerebral artery (MCA) in male spontaneously hypertensive stroke-prone rats (SHRSP). Therefore, we hypothesized that MR antagonism would reduce ischemic infarct size and prevent MCA remodeling in female SHRSP. Six-week-old female SHRSP were treated for 6 wk with spironolactone (25 or 50 mg·kg^–1·day^–1) or eplerenone (100 mg·kg^–1·day^–1) and compared with untreated controls. At 12 wk, cerebral ischemia was induced for 18 h using the intraluminal suture occlusion technique, or the MCA was isolated for analysis of passive structure using a pressurized arteriograph. MR antagonism had no effect on infarct size or passive MCA structure in female SHRSP. To study the potential effects of estrogen, the above experiments were repeated in bilaterally ovariectomized (OVX) female SHRSP treated with spironolactone (25 mg·kg^–1·day^–1). Infarct size and vessel structure in OVX SHRSP were not different from control SHRSP. Spironolactone had no effect on infarct size in OVX SHRSP. However, MCA lumen and outer diameters were increased in spironolactone-treated OVX SHRSP, suggesting an effect of estrogen. Cerebral artery MR expression, assessed by Western blotting, was increased in female, compared with male, SHRSP. These studies highlight an apparent sexual dimorphism of MR expression and activity in the cerebral vasculature from hypertensive rats.

sex differences; cerebral ischemia; vascular remodeling; spironolactone; eplerenone; spontaneously hypertensive stroke-prone rats; middle cerebral artery

This article has been cited by other articles:

				K. Sachidanandam, J. R. Hutchinson, M. M. Elgebaly, E. M. Mezzetti, M.-H. Wang, and A. Ergul Differential Effects of Diet-Induced Dyslipidemia and Hyperglycemia on Mesenteric Resistance Artery Structure and Function in Type 2 Diabetes J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 123 - 130. [Abstract] [Full Text] [PDF]